Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $69.81 +6.76%
EPS Growth %: +26.6%
Financial Fact:
General and administrative: 10.25M
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: +26.6%
Financial Fact:
General and administrative: 10.25M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($1.78). Revenue for the quarter came in at $21.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
- After-Hours Stock Movers: NKE, BE, STZ, RIG
- Corona-maker Constellation Brands beats estimates, shares jump 2%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
